SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: CuttingEdge Bio who wrote (3446)2/13/2022 11:07:42 PM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 3557
 
investor.regeneron.com
Slide 8
What is a point of argue????

David asked "why" and I said no idea, .....due to schedule and plan! Dosing regiment was THE SAME for both arm!



To: CuttingEdge Bio who wrote (3446)2/13/2022 11:14:00 PM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 3557
 
<4 weeks following the shot (of either dose) would be the same, as it is at all previous analogous timepoints (week 12, week 24, week 36), and you would want to know what happens at week 56 to compare the two doses, not week 48.>

So, REGN and Bayer FUXXX UP again, because their primary end-point for p3 is 48 weeks!!!! Maybe we all should go SHORT before data release!???


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News